Genocea OTC Stock Financials

GGNNW -  USA Stock  

USD 0.0121  0.00  0.00%

Understanding current and past Genocea Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genocea Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Genocea Biosciences' assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Genocea Biosciences' financials over time to get the whole picture.
We strongly advise to harness Genocea Biosciences fundamental analysis to find out if markets are presently mispricing the company. Simply put you can make use of it to find out if Genocea Biosciences is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate two available reported financial drivers for Genocea Biosciences, which can be compared to its competitors. Please be adviced to check out Genocea Biosciences market capitalization to decide if Genocea Biosciences is mispriced or priced some-what accurately. Use Genocea Biosciences to protect your portfolios against small market fluctuations. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Genocea Biosciences to be traded at $0.012 in 90 days.

Genocea Fundamentals 

With this module, you can analyze Genocea financials for your investing period. You should be able to track the changes in Genocea Biosciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
The data published in Genocea Biosciences' official financial statements usually reflect Genocea Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Genocea Biosciences. For example, before you start analyzing numbers published by Genocea accountants, it's critical to develop an understanding of what Genocea Biosciences' liquidity, profitability, and earnings quality are in the context of the Genocea Biosciences space in which it operates.
Please note, the presentation of Genocea Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genocea Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Genocea Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genocea Biosciences. Please utilize our Beneish M Score to check the likelihood of Genocea Biosciences' management to manipulate its earnings.
InstrumentUSA OTC Stock View All
ExchangeOTC Exchange
CurrencyUSD - US Dollar

Genocea Biosciences Market Fundamentals

 Change(%) 0.00 

About Genocea Biosciences Financials

What exactly are Genocea Biosciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Genocea Biosciences' income statement, its balance sheet, and the statement of cash flows. Potential Genocea Biosciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Genocea Biosciences investors may use each financial statement separately, they are all related. The changes in Genocea Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Genocea Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Genocea Biosciences October 19, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Genocea Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genocea Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genocea Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Genocea OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genocea Biosciences's daily price indicators and compare them against related drivers.
Downside Deviation72.71
Information Ratio0.0841
Maximum Drawdown99981.5
Value At Risk(70.00)
Potential Upside66.67
Please check Risk vs Return Analysis. Note that the Genocea Biosciences information on this page should be used as a complementary analysis to other Genocea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Genocea OTC Stock analysis

When running Genocea Biosciences price analysis, check to measure Genocea Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genocea Biosciences is operating at the current time. Most of Genocea Biosciences' value examination focuses on studying past and present price action to predict the probability of Genocea Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Genocea Biosciences' price. Additionally, you may evaluate how the addition of Genocea Biosciences to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
The market value of Genocea Biosciences is measured differently than its book value, which is the value of Genocea that is recorded on the company's balance sheet. Investors also form their own opinion of Genocea Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Genocea Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genocea Biosciences' market value can be influenced by many factors that don't directly affect Genocea Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genocea Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Genocea Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genocea Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.